Eastgate Biotech CEO, Anna Gluskin, Talks about Developing First Insulin Delivery Method by Oral Administration

Eastgate Biotech CEO, Anna Gluskin, Talks about Developing First Insulin Delivery Method by Oral Administration

Anna Gluskin, CEO for Eastgate Biotech Corp. (ETBI), returns to the show with Everett Jolly and they discuss being the first company to develop an insulin delivery method done with oral administration.

EBTI

 

We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.

Leave a Reply

Close Menu